81 related articles for article (PubMed ID: 11227994)
1. Antiviral activity of mixed-valence rare earth borotungstate heteropoly blues against influenza virus in mice.
Liu J; Mei W; Li Y; Wang E; Ji L; Tao P
Antivir Chem Chemother; 2000 Nov; 11(6):367-72. PubMed ID: 11227994
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo investigations on the antiviral activity of a series of mixed-valence rare earth borotungstate heteropoly blues.
Liu YN; Shi S; Mei WJ; Tan CP; Chen LM; Liu J; Zheng WJ; Ji LN
Eur J Med Chem; 2008 Sep; 43(9):1963-70. PubMed ID: 18342405
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates.
Liu J; Mei WJ; Xu AW; Tan CP; Shi S; Ji LN
Antiviral Res; 2004 Apr; 62(1):65-71. PubMed ID: 15026204
[TBL] [Abstract][Full Text] [Related]
4. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
5. Antiviral compounds. XII. Antiviral activity of amidinohydrazones of alkoxyphenyl-substituted carbonyl compounds against influenza virus in eggs and in mice.
Nishimura T; Toku H; Fukuyasu H
Kitasato Arch Exp Med; 1977 Jun; 50(1-2):39-46. PubMed ID: 616473
[No Abstract] [Full Text] [Related]
6. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
[TBL] [Abstract][Full Text] [Related]
7. Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice.
Walker JS; Stephen EL; Spertzel RO
J Infect Dis; 1976 Jun; 133 Suppl():A140-4. PubMed ID: 932501
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
Chand P; Bantia S; Kotian PL; El-Kattan Y; Lin TH; Babu YS
Bioorg Med Chem; 2005 Jun; 13(12):4071-7. PubMed ID: 15911320
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
Rees WA; Harkins JD; Lu M; Holland RE; Lehner AF; Tobin T; Chambers TM
Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485
[TBL] [Abstract][Full Text] [Related]
11. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF
Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ribavirin against influenza virus in tissue culture and in mice.
Durr FE; Lindh HF
Ann N Y Acad Sci; 1975 Aug; 255():366-71. PubMed ID: 1059365
[No Abstract] [Full Text] [Related]
13. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
Smee DF; Wandersee MK; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2004 Sep; 15(5):261-8. PubMed ID: 15535048
[TBL] [Abstract][Full Text] [Related]
16. Influenza virus growth and antibody response in amantadine-treated mice.
Davies WL; Grunert RR; Hoffmann CE
J Immunol; 1965 Dec; 95(6):1090-4. PubMed ID: 5850540
[No Abstract] [Full Text] [Related]
17. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
Gao RM; Li XQ; He WY; Jiang JD; Li YH
Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
[TBL] [Abstract][Full Text] [Related]
18. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ
J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of exopolysaccharide from Aphanothece halophytica (Chroococcales) significantly inhibits influenza virus (H1N1)-induced pneumonia in mice.
Zheng W; Chen C; Cheng Q; Wang Y; Chu C
Int Immunopharmacol; 2006 Jul; 6(7):1093-9. PubMed ID: 16714212
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and anti-influenza virus activities of heteropoly compounds containing rare earth elements].
Liu J; Wang E; Zhou Y; Hu C
Yao Xue Xue Bao; 1998 Jul; 33(7):544-7. PubMed ID: 12016890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
